Migraine Trust International Symposium Patient Day
About the event
The Migraine Trust International Symposium Patient Day is back.
This hybrid event will include presentations from and Q&A sessions with leading migraine specialists.
There will also be an interview with Professor Peter Goadsby, whose joint research resulted in the development of the new calcitonin gene-related peptide (CGRP) antibody medication, the first medication designed to prevent migraine. He is also the winner of this year’s Brain Prize.
Take part in the way that suits you, by coming along to the event or joining virtually over Zoom.
We are pleased to announce that this event will be made more accessible with a BSL translator at our in-person event and subtitles available for those attending virtually.